The Maimonides Biomedical Research Institute of Cordoba – IMIBIC, is a joint Institute of the University of Cordoba (UCO), the Reina Sofia University Hospital, and the Junta de Andalucía Regional government. IMIBIC brings together scientific research and medical practice to embrace integral projects with the ultimate aim to promote a much faster and efficient communication between clinical and preclinical research, and to generate knowledge of high impact with considerable potential of translation into practice, new therapies and innovative products.
VCE-004.8 has been evaluated in a preclinical model of metabolic syndrome induced by high fat diet in collaboration with Dr. Manuel Tena-Sempere, a full Professor of Physiology at the University of Córdoba (IMIBIC). The data on the anti-obesity activity of VCE-004.8 have been reported in the Scientific Reports (2018). In addition, a collaboration is ongoing with the proteomic unit and Prof. Eduardo Muñoz at the IMBIC to analyze plasmatic drug-related biomarkers.